Full-Time

Regulatory Affairs Manager

Confirmed live in the last 24 hours

Ceribell

Ceribell

201-500 employees

EEG devices for monitoring brain activity

Healthcare

Compensation Overview

$130k - $170kAnnually

+ Bonus + Equity

Mid

Sunnyvale, CA, USA

Category
Risk & Compliance
Legal & Compliance
Requirements
  • 4-6 years of experience in medical device regulatory affairs (consulting experience preferred)
  • Bachelor's degree in a biological, scientific, or engineering field (Master's preferred)
  • Direct experience in drafting medical device submissions
  • Experience interacting with regulatory authorities
  • Ability to work collaboratively in a fast-paced environment while managing multiple priorities.
Responsibilities
  • Manage regulatory strategy and submissions for key product initiatives
  • Collaborate cross-functionally to compile, review, and submit regulatory submissions to authorities and respond to subsequent requests for information
  • Develop documentation to satisfy CE Mark maintenance requirements as specified by the EU MDR
  • Advise development teams on product design strategy as it relates to regulatory pathways and compliance
  • Effectively communicate regulatory strategies and progress to internal stakeholders
  • Identify applicable standards, regulations, and FDA guidance documents and assist in their interpretation and resulting compliance strategies.

Ceribell focuses on developing medical devices that utilize electroencephalogram (EEG) technology to monitor brain activity. Their main product, the Ceribell EEG Headband and Recorder, is designed for use by trained healthcare providers in professional settings. These devices help gather important data on a patient's brain activity, which is essential for diagnosing and treating neurological conditions, particularly in urgent situations like Nonconvulsive Status Epilepticus (NCSE). Unlike some other medical devices, the Ceribell EEG Recorder does not provide diagnostic conclusions or automated alerts; instead, it serves as a tool for healthcare professionals to collect data for interpretation. Ceribell differentiates itself by focusing on the speed of data collection, which is critical in time-sensitive medical scenarios. The company's goal is to enhance the ability of healthcare providers to make informed treatment decisions quickly, ultimately improving patient outcomes.

Company Stage

Series C

Total Funding

$146.9M

Headquarters

Mountain View, California

Founded

2014

Growth & Insights
Headcount

6 month growth

11%

1 year growth

25%

2 year growth

63%
Simplify Jobs

Simplify's Take

What believers are saying

  • Ceribell's recent $102 million equity investment and $50 million financing round indicate strong financial backing for expansion and product development.
  • The appointment of experienced leaders like Sean Manni and Joshua Copp positions the company for strategic growth and operational excellence.
  • Recognition by Fast Company as one of the World's Most Innovative Companies highlights Ceribell's industry impact and potential for continued innovation.

What critics are saying

  • The reliance on healthcare providers to interpret EEG data may limit the device's adoption in settings with less specialized staff.
  • The competitive landscape in medical devices and AI-powered diagnostics could pose challenges to Ceribell's market share.

What makes Ceribell unique

  • Ceribell's AI-powered point-of-care EEG system is a first-of-its-kind technology, setting it apart from traditional EEG devices.
  • The company's focus on rapid, easy-to-use brain monitoring solutions for time-critical conditions like NCSE provides a unique value proposition.
  • FDA Breakthrough Device Designation for delirium detection further validates Ceribell's innovative approach in neurodiagnostics.

Help us improve and share your feedback! Did you find this helpful?